Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS · Delayed Price · Currency is USD
0.6000
0.00 (0.00%)
Sep 3, 2025, 11:05 AM EDT
Pharma-Bio Serv Market Cap
Pharma-Bio Serv has a market cap or net worth of $13.76 million as of September 3, 2025. Its market cap has decreased by -33.44% in one year.
Market Cap
13.76M
Enterprise Value
3.46M
Revenue
9.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.60
Market Cap Chart
Since December 4, 2006, Pharma-Bio Serv's market cap has decreased from 32.89M to 13.76M, a decrease of -58.18%. That is a compound annual growth rate of -4.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 13.76M | 8.97% |
| Dec 30, 2024 | 12.62M | -47.64% |
| Dec 28, 2023 | 24.11M | 33.02% |
| Dec 30, 2022 | 18.13M | -23.58% |
| Dec 31, 2021 | 23.72M | -28.88% |
| Dec 31, 2020 | 33.35M | 66.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |